Skip to search formSkip to main contentSkip to account menu

GSK923295

National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

Bridged Bicyclo Compounds, HeterocyclicSarcosine

Narrower (1)

GSK923295A
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Pgp efflux pump decreases the cytostatic effect of CENP-E inhibitor GSK923295.
2010
2010
Targeting a kinetochore-associated motor protein to kill cancer cells
Tumors are characterized by excessive proliferation and, therefore, chemotherapeutics that target proteins involved in tumor cell… 
2010
2010
Phase I first-in-human study of the centromere-associated protein E (CENP-E) inhibitor GSK923295 in patients with advanced solid tumors (study CPE107602).
3012 Background: CENP-E plays a key role in maintaining and silencing mitotic checkpoint signaling. CENP-E is overexpressed in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)